WHO ICTRP trial

Comparison of body weight, blood sugar level and lipid profile with atypical…

CTRI/2014/10/005144 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2014/10/005144
Public title Comparison of body weight, blood sugar level and lipid profile with atypical antipsychotics olanzapine versus iloperidone
Scientific title Comparative evaluation of effects of olanzapine versus iloperidone on body mass index, blood sugar level and lipid profile in patients with psychosis
Primary sponsor Rohilkhand Medical College And Hospital
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: null- Patients of Psychosis, ICD 10, f20-f29 criteria- Schizophrenia, Schizoaffective disorder, persistant delusional disorder, acute and transient psychosis.
Interventions Intervention1: Iloperidone: 4mg BD orally for 12 months duration Control Intervention1: atypical antipsychotic agents- olanzapine: olanzapine 10mgOD,Orally for 12 months duration
Registration date Oct 27, 2014
Target size 100
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations